A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen
Neal Van Hoeven(Sana Biotechnology (United States)), Rhea N. Coler(Infectious Disease Research Institute), Scott B. Winram(Leidos (United States)), David E. Clements(Hawaii Biotech (United States)), Christopher B. Fox(Utah State University), Andrew Fioré-Gartland(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Steven R. Wiley(NOAA National Marine Fisheries Service Northwest Fisheries Science Center), Steven G. Reed(Infectious Disease Research Institute), Emily Gage(Infectious Disease Research Institute), Sean A. Gray(PAI Life Sciences (United States)), Brian Granger(Infectious Disease Research Institute), D E Parks(Hawaii Biotech (United States)), Dan T. Stinchcomb(Harvard University)
Cited by 29
Related Papers
High-frequency transformation of yeast: autonomous replication of hybrid DNA molecules.
|Proceedings of the National Academy of Sciences|1979|1.5k
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
|Nature Medicine|2007|1.4k
Key roles of adjuvants in modern vaccines
|Nature Medicine|2013|1.4k
Sterile host yeasts (SHY): A eukaryotic system of biological containment for recombinant DNA experiments
|Gene|1979|961
Isolation and characterisation of a yeast chromosomal replicator
|Nature|1979|779